Ann Intern Med. 2008 Aug 5;149(3):185-91. doi: 10.7326/0003-4819-149-3-200808050-00008.
Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer.
The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer screening; cohort and cross-sectional studies of the psychological harms of false-positive prostate-specific antigen test results; and evidence on the natural history of prostate-specific antigen-detected prostate cancer to address previously identified gaps in the evidence from the 2002 USPSTF recommendation.
Current evidence is insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years (I statement). Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation).
2002年美国预防服务工作组(USPSTF)关于前列腺癌筛查的推荐声明更新。
USPSTF评估了前列腺癌筛查益处的随机对照试验;前列腺特异性抗原检测结果假阳性的心理危害的队列研究和横断面研究;以及前列腺特异性抗原检测出的前列腺癌自然史的证据,以解决2002年USPSTF推荐中先前发现的证据空白。
目前的证据不足以评估75岁以下男性前列腺癌筛查的利弊平衡(I类声明)。75岁及以上男性不进行前列腺癌筛查(D级推荐)。